Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Farmers Insurance
Mallinckrodt
Citi
Dow
Moodys
Queensland Health
Johnson and Johnson
US Department of Justice

Generated: October 16, 2018

DrugPatentWatch Database Preview

Drugs in Development Information for Anamorelin

« Back to Dashboard

US Patents for Anamorelin

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Anamorelin ➤ Try a Free Trial Compound with growth hormone releasing properties Novo Nordisk A/S (Bagsvaerd, DK) ➤ Try a Free Trial
Anamorelin ➤ Try a Free Trial Crystal forms of (3R)-1-(2-methylalanyl-D-tryptophyl)-3-(phenylmethyl)-3-piperidinecarboxy- lic acid 1,2,2-trimethylhydrazide Helsinn Therapeutics (U.S.), Inc. (Bridgewater, NJ) ➤ Try a Free Trial
Anamorelin ➤ Try a Free Trial Method of stimulating the motility of the gastrointestinal system using growth hormone secretagogues Helsinn Therapeutics (U.S.), Inc. (Bridgewater, NJ) ➤ Try a Free Trial
Anamorelin ➤ Try a Free Trial Methods of treating emesis using growth hormone secretagogues Helsinn Therapeutics (U.S.), Inc. (Bridgewater, NJ) ➤ Try a Free Trial
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Anamorelin

Drugname Country Document Number Estimated Expiration Related US Patent
Anamorelin Austria 280168 2019-11-10 ➤ Try a Free Trial
Anamorelin Australia 1269401 2019-11-10 ➤ Try a Free Trial
Anamorelin Australia 782260 2019-11-10 ➤ Try a Free Trial
Anamorelin Brazil 0015407 2019-11-10 ➤ Try a Free Trial
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
US Army
Queensland Health
Farmers Insurance
Cantor Fitzgerald
UBS
Johnson and Johnson
US Department of Justice
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.